Whitlock Patrick W, Smith Thomas L, Poehling Gary G, Shilt Jeffrey S, Van Dyke Mark
Department of Orthopaedic Surgery, Institute for Regenerative Medicine, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA.
Biomaterials. 2007 Oct;28(29):4321-9. doi: 10.1016/j.biomaterials.2007.05.029. Epub 2007 Jul 3.
Tissue-engineered tendon scaffolds have the potential to significantly improve the treatment of tendon and ligament injuries, especially those associated with tumors, trauma, and congenital deficiencies where autograft or allograft tissue might not be available in sufficient quantity for reconstruction. In this study, a tendon scaffold was produced that: (1) has decreased/absent cellular material histologically, as well as significantly decreased DNA content in comparison with the material it is derived from-fresh-frozen flexor digitorum profundus tendon; (2) is cytocompatible in vitro; (3) has been modified to produce increased pore size and porosity; (4) retains 76-78% of the tensile properties of the material it is derived from; (5) is readily infiltrated by fibroblast-like, mononuclear host cells; and (6) does not exhibit a host-cell-mediated foreign-body immune response after implantation in vivo.
组织工程化肌腱支架有潜力显著改善肌腱和韧带损伤的治疗,尤其是那些与肿瘤、创伤和先天性缺陷相关的损伤,在这些情况下,自体移植或异体移植组织可能数量不足,无法用于重建。在本研究中,制备了一种肌腱支架,其具有以下特点:(1) 组织学上细胞物质减少或缺失,与它所源自的新鲜冷冻指深屈肌腱相比,DNA含量也显著降低;(2) 在体外具有细胞相容性;(3) 已被改性以增加孔径和孔隙率;(4) 保留了其所源自材料76 - 78%的拉伸性能;(5) 容易被成纤维细胞样单核宿主细胞浸润;(6) 在体内植入后不表现出宿主细胞介导的异物免疫反应。